Holen Sie sich die Stockscreener-App
10.93
0.18%
0.0199
Handel nachbörslich:
10.93
Schlusskurs vom Vortag:
$10.91
Offen:
$10.92
24-Stunden-Volumen:
26,309
Relative Volume:
0.29
Marktkapitalisierung:
$18.83M
Einnahmen:
$8.62M
Nettoeinkommen (Verlust:
$-6.15M
KGV:
-0.9909
EPS:
-11.03
Netto-Cashflow:
$-5.32M
1W Leistung:
+0.46%
1M Leistung:
+2.25%
6M Leistung:
+215.52%
1J Leistung:
+159.00%
1-Tages-Spanne:
$10.92
$10.94
1-Wochen-Bereich:
$10.85
$10.94
52-Wochen-Spanne:
$1.94
$10.94
Evoke Pharma Inc Stock (EVOK) Company Profile
Firmenname
Evoke Pharma Inc
Sektor
Telefon
858-345-1494
Adresse
420 STEVENS AVENUE, SOLANA BEACH, CA
Vergleichen Sie EVOK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
10.93 | 18.84M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
118.65 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.18 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.46 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
489.31 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Fortgesetzt | FBR & Co. | Buy |
| 2017-03-16 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-01-30 | Hochstufung | Laidlaw | Neutral → Buy |
| 2017-01-05 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Bestätigt | Rodman & Renshaw | Neutral |
| 2016-07-19 | Bestätigt | FBR Capital | Outperform |
| 2016-07-19 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-07-18 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Eingeleitet | Northland Capital | Outperform |
| 2016-03-14 | Bestätigt | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Fortgesetzt | FBR Capital | Outperform |
| 2014-12-03 | Bestätigt | MLV & Co | Buy |
| 2014-11-07 | Eingeleitet | MLV & Co | Buy |
| 2014-04-22 | Eingeleitet | Laidlaw | Buy |
| 2013-11-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
How Low Can Evoke Pharma Stock Really Go? - Trefis
Will Evoke Pharma Inc. stock deliver shareholder valueJuly 2025 Sentiment & Technical Confirmation Alerts - Newser
Halper Sadeh LLC Encourages EVOK, FSFG, BRY Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Is Evoke Pharma Inc. stock trading near support levelsJuly 2025 Price Swings & Weekly Chart Analysis and Trade Guides - BỘ NỘI VỤ
Financial Comparison: Assembly Biosciences (NASDAQ:ASMB) versus Evoke Pharma (NASDAQ:EVOK) - Defense World
How Evoke Pharma Inc. stock performs after earningsTrade Analysis Report & Target Return Focused Picks - BỘ NỘI VỤ
Where Analysts See Suraj Industries Ltd Stock by YearEndRSI Overbought/Oversold & Analyze Your Portfolio Risk in Seconds - earlytimes.in
Why Evoke Pharma Inc. stock attracts global investorsJuly 2025 Opening Moves & Smart Investment Allocation Tips - BỘ NỘI VỤ
Analyzing Evoke Pharma (NASDAQ:EVOK) & Assembly Biosciences (NASDAQ:ASMB) - Defense World
KLEIN ROGER M Insider Trades - Nasdaq
Evoke Pharma Inc. (EVOK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Evoke Pharma (EVOK-Q) Analyst Research & Price Targets - The Globe and Mail
How Evoke Pharma Inc. stock reacts to bond yields2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Why retail investors favor Evoke Pharma Inc. stockEarnings Recap Report & Real-Time Volume Triggers - newser.com
Evaluating Evoke Pharma Inc. with trendline analysisJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
How to read the order book for Evoke Pharma Inc.Earnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Evoke Pharma Inc. stock go up soon2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Using economic indicators to assess Evoke Pharma Inc. potential2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com
Will Evoke Pharma Inc. stock continue dividend increasesInsider Buying & Safe Capital Allocation Plans - newser.com
What drives Evoke Pharma Inc stock priceStock Buyback Updates & Rapid Portfolio Growth - earlytimes.in
Risk vs reward if holding onto Evoke Pharma Inc.2025 Year in Review & High Accuracy Trade Alerts - newser.com
Evoke Pharma Reports Increased Sales Amid Ongoing Losses - MSN
What valuation multiples suggest for Evoke Pharma Inc. stock2025 Price Momentum & Breakout Confirmation Alerts - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-COMP, HFWA, EVOK, and JTAI - The Malaysian Reserve
[SC TO-T] Evoke Pharma Inc Third-Party Tender Offer | EVOK SEC FilingForm SC TO-T - Stock Titan
Evoke Pharma’s Merger Uncertainty: Potential Risks to Business Operations and Financial Health - MSN
How currency fluctuations impact Evoke Pharma Inc. stockJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
Identifying reversal signals in Evoke Pharma Inc.Weekly Trade Analysis & Stock Portfolio Risk Management - newser.com
Using Bollinger Bands to evaluate Evoke Pharma Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Advanced analytics toolkit walkthrough for Evoke Pharma Inc.2025 Key Highlights & Technical Pattern Alert System - newser.com
Why Evoke Pharma Inc. stock is a value investor pickPrice Action & AI Driven Stock Movement Reports - newser.com
Price action breakdown for Evoke Pharma Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE - The Malaysian Reserve
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):